Canada Spends Logo

Explore our Budget 2026 analysis

Grant: DSEN team grants: MAGIC and CAN-AIM

Research Institute of the McGill University Health Centre

$2,550,000.00

Enhancing CAN-AIM capacity to respond to drug safety and effectiveness queries

FY 2019-20

Summary
The CAnadian Network for Advanced Interdisciplinary Methods for comparative effectiveness research' (CAN-AIM) team is a pan-Canadian, highly interdisciplinary network of researchers working together to provide real-world information about drug safety and effectiveness for policymakers. Since the beginning, we have improved the validity and accuracy of Canadian research on the safety or benefits of particular drugs. Our aim is to continue to build on our team's expertise, develop methods to respond even more timely to future stakeholder queries and utilise novel sources of data to respond to queries. To achieve this, we are focusing on five main goals: -Improving data access and data enrichment with existing cohorts and supporting linkage of this data with administrative databases to optimize drug safety and effectiveness analyses; -Increasing collaboration between DSEN teams; -Creating tools to anticipate drug safety and effectiveness queries; -Improving analytical methods, including the use of new analytical methods to study gender/sex interactions in comparative effectiveness analysis; -Expanding ongoing research programs. We aim to make our research even more relevant for regulators through webinar series and seminars on relevant topics. We will also communicate with knowledge users to best understand stakeholder needs. Decision-makers need timely and relevant information to make informed-decisions on the safety or benefits of particular drugs. The next three years of activity will see CAN-AIM redouble its efforts to ensure that we are truly an indispensable agent of change for Canadian decision makers.
Program
DSEN team grants: MAGIC and CAN-AIM
Location
Quebec, Canada
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
405640
Name
Bernatsky Sasha R
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Health Services and Policy Research
Theme2
Social / Cultural / Environmental / Population Health
Prcname2
DSEN team grants: MAGIC and CAN-AIM
Projecttitle
Enhancing CAN-AIM capacity to respond to drug safety and effectiveness queries
Programtype2
Directed Grant
Orgnameinp2
Research Institute of the McGill University Health Centre
Cihramount2
$2,550,000
Cihrequipment2
$0
Programname2
DSEN team grants: MAGIC and CAN-AIM
Keyworddelim
Comparative Effectiveness And Safety; Confounding Bias; Exposure Measurement Errors; Pharmacoepidemiology; Prospective Studies; Statistical Modelling
Abstract
The CAnadian Network for Advanced Interdisciplinary Methods for comparative effectiveness research' (CAN-AIM) team is a pan-Canadian, highly interdisciplinary network of researchers working together to provide real-world information about drug safety and effectiveness for policymakers. Since the beginning, we have improved the validity and accuracy of Canadian research on the safety or benefits of particular drugs. Our aim is to continue to build on our team's expertise, develop methods to respond even more timely to future stakeholder queries and utilise novel sources of data to respond to queries. To achieve this, we are focusing on five main goals: -Improving data access and data enrichment with existing cohorts and supporting linkage of this data with administrative databases to optimize drug safety and effectiveness analyses; -Increasing collaboration between DSEN teams; -Creating tools to anticipate drug safety and effectiveness queries; -Improving analytical methods, including the use of new analytical methods to study gender/sex interactions in comparative effectiveness analysis; -Expanding ongoing research programs. We aim to make our research even more relevant for regulators through webinar series and seminars on relevant topics. We will also communicate with knowledge users to best understand stakeholder needs. Decision-makers need timely and relevant information to make informed-decisions on the safety or benefits of particular drugs. The next three years of activity will see CAN-AIM redouble its efforts to ensure that we are truly an indispensable agent of change for Canadian decision makers.
Competitiondate
201904
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Bernatsky, Sasha R; Abrahamowicz, Michal M; Afif, Waqqas; Awadalla, Philip; Bérard, Anick; Buckeridge, David L; Hazlewood, Glen S; Hohl, Corinne M; Kowalec, Kaarina A; Moride, Yola; Moura, Cristiano S; Pilote, Louise; Tremlett, Helen L
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $2,550,000~ $0~